MYLAN LABS LTD drug pipeline, international patents

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Labs Ltd	MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER	moxifloxacin hydrochloride	SOLUTION;INTRAVENOUS	205833-001	May 5, 2017		RX	No	Yes		⤷ Subscribe				⤷ Subscribe
Mylan Labs Ltd	NORETHINDRONE AND ETHINYL ESTRADIOL	ethinyl estradiol; norethindrone	TABLET;ORAL-28	200486-001	Dec 28, 2015		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Mylan Labs Ltd	DEXMEDETOMIDINE HYDROCHLORIDE	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	212571-002	Aug 27, 2020	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Mylan Labs Ltd	DOXORUBICIN HYDROCHLORIDE	doxorubicin hydrochloride	INJECTABLE;INJECTION	200170-002	Oct 28, 2011	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Mylan Labs Ltd	NORETHINDRONE AND ETHINYL ESTRADIOL	ethinyl estradiol; norethindrone	TABLET;ORAL-28	200489-001	Oct 21, 2015		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Mylan Labs Ltd	ETOMIDATE	etomidate	INJECTABLE;INJECTION	201044-001	Feb 7, 2017	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Mylan Labs Ltd	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	203851-003	Nov 30, 2017	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Mylan Labs Ltd Company Profile